1.Study on the effect and safety of ciprofol combined with local anesthesia on elderly patients undergoing hemor-rhoidectomy
Jiahui FENG ; Helin ZOU ; Fujun LI
China Pharmacy 2025;36(8):970-974
OBJECTIVE To evaluate the effect and safety of ciprofol combined with local anesthesia on elderly patients undergoing hemorrhoidectomy. METHODS A total of 108 elderly patients who underwent hemorrhoidectomy at the Department of Proctology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine from February 2023 to June 2024, were included. The patients were randomly divided into the etomidate group (54 cases) and the ciprofol group (54 cases) based on a computer-generated random sequence. One patient with intraoperative bleeding and one who refused postoperative examination were excluded, resulting in a final total of 106 patients completing this trial (52 in the etomidate group and 54 in the ciprofol group). The two groups of patients underwent hemorrhoidectomy under local anesthesia with sedative assistance, receiving either etomidate at 0.2 mg/kg or ciprofol at 0.3 mg/kg combined with sufentanil at 0.1 μg/kg. The sedation success rate, induction time, recovery time, operation time and hemodynamic parameters [heart rate (HR), mean arterial pressure (MAP), pulse oxygen saturation (SpO2) and respiratory rate (RR)] were observed at baseline (T0), after successful induction of anesthesia (T1), 10 minutes after the start of surgery (T2), and awakening (T3). Additionally, the levels of oxidative stress markers [malondialdehyde (MDA) and superoxide dismutase (SOD)] were measured at T0, T2 and T3. The occurrence of adverse reactions was also recorded. RESULTS The induction time of the ciprofol group was significantly shorter than that of the etomidate group (P<0.05), while the recovery time was significantly longer in the ciprofol group compared to the etomidate group (P<0.05). AtT1 and T2, HR, MAP and RR of two groups were significantly lower compared to the same group at T0 (P<0.05). However, no significant differences were observed in the hemodynamic parameters at each time point between the two groups (P>0.05). At T2 and T3, the MDA levels in both groups were significantly higher than at T0, while the SOD levels were significantly lower than the same group at T0; the ciprofol group showed significantly better outcomes than the etomidate group at the same time points (P<0.05). The proportion of patients with intraoperative somatic movements was significantly lower in the ciprofol group compared to the etomidate group (P<0.05). CONCLUSIONS When ciprofol is used in elderly patients undergoing hemorrhoidectomy, it demonstrates certain advantages over etomidate in maintaining hemodynamic stability and reducing oxidative stress. Additionally, ciprofol has higher safety.
2.Advances in construction and applications of quantitative adverse outcome pathways in toxicology
Mintao LI ; Jiahui CHEN ; Beibei JIANG ; Jie GAO ; Jiali ZOU ; Qianru ZHOU ; Xiaofeng YAN ; Shuquan LUO ; Huadong ZHANG ; Jinyao CHEN ; Xuemei LIAN ; Jiao HUO
Chinese Journal of Pharmacology and Toxicology 2024;38(6):473-480
"Toxicity Testing in the 21st Century—A Vision and Strategy"proposed by the National Research Council of US has brought innovative directives and objectives for toxicity evaluation and risk assessment,pushing forward the next generation of toxicity testing and risk assessment.In this initiative,the concept of adverse outcome pathways(AOPs)has emerged as a prominent methodology,capturing the attention of toxicologists and researchers due to its promising applications in recent years.The quantitative AOP(qAOP)is an extension of the adverse outcome pathway,which is built upon the foundational qualitative adverse outcome pathway model and leverages mathematical frame-works to depict dose-response and/or response-response relationships.This article reviews the princi-ples and advancement surrounding qAOP,introduceds two prevalent methodologies for constructing qAOP,Bayesian network models and regression models,and demonstrates diverse applications of qAOP.Actual cases are used to underscore the transformative role of qAOP in contemporary toxicology and risk assessment practices.
3.Visual analysis of emergency palliative care based on Web of Science database
Xuefei WU ; Shengqiang ZOU ; Yun YE ; Chunhua GE ; Jiahui LI ; Jing XIE
Chinese Journal of Modern Nursing 2024;30(7):913-919
Objective:To conduct the visual analysis of emergency palliative care based on the Web of Science database.Methods:The literature on emergency palliative care collected from 2012 to 2022 was systematically searched in the Web of Science core collection. CiteSpace software was used for visual analysis.Results:A total of 630 articles were included, and the number of publications was on the rise. The country with the highest number of publications was the United States, with 8 out of the top 10 institutions in terms of publication volume coming from the United States. The author with the highest number of publications was Grudzen. The top 10 journals in terms of citation frequency were mostly specialized journals on palliative care and first aid. The results of keyword analysis showed that a total of 15 clustering labels and 20 emergent words were output, reflecting the changes of key research objects, main research types and areas of concern.Conclusions:At present, nursing research in this field is in the development stage in China. We can draw on the practical experience of foreign countries to further explore the emergency palliative care model and service system based on China's national conditions.
4.Research progress of screening tools for palliative care needs in emergency patients before referral at home and abroad
Xuefei WU ; Shengqiang ZOU ; Chunhua GE ; Changfeng MAN ; Jiahui LI ; Jing XIE ; Xiyang LIU
Chinese Journal of Nursing 2024;59(14):1786-1793
The timely use of screening tools to assess the palliative care needs of emergency patients can provide decision-making basis for patient referral and help patients receive palliative care in a timely manner.This paper reviews the palliative care needs screening tools for emergency patients at home and abroad,describes their development methods,scoring criteria and application status,compares and analyzes their characteristics and shortcomings.It aims to provide references for the localized development and application of palliative care needs screening tools in emergency patients.
5.Visual analysis in studies at home and abroad on postoperative cognitive impairment based on CiteSpace software
Qi ZHOU ; Yiting WANG ; Shengqiang ZOU ; Jiahui LI ; Xihu YANG
Journal of Clinical Medicine in Practice 2024;28(8):1-6
Objective To analyze the publication profile and research hotspots of studies at home and abroad on postoperative cognitive dysfunction by bibliometric methods. Methods Literatures related to postoperative cognitive dysfunction published in the China National Knowledge Infrastructure (CNKI) and Web of Science databases from 2013 to 2023 were included, and statistical analysis was conducted by CiteSpace software. Results A total of 2 705 Chinese literatures and 2 412 English core literatures were included. The number of literatures on postoperative cognitive dysfunction showed an annual increase from 2013 to 2023; China was the country with the highest number of publications internationally, with Capital Medical University ranking the top among Chinese institutions; domestically, postoperative cognitive dysfunction researches predominantly focused on clinical studies, while overseas researches emphasized pathological mechanisms and basic investigations. Research hotspot analysis revealed an enhanced interest in the inflammatory mechanisms and anesthetic aspects of postoperative cognitive dysfunction. Conclusion From 2013 to 2023, the overall research at home and abroad interest in postoperative cognitive dysfunction has shown an upward trend, yet its pathophysiological mechanisms need further exploration. The risk factors for postoperative cognitive impairment and their correlations with anesthesia and mortality are being actively explored, and new methods for prevention and treatment such as percutaneous electrical stimulation are gradually emerging.
6.Pharmacodynamic substances and mechanism of Chelidonii Herba-Corydalis Rhizoma against estrogen receptor-positive breast cancer
Xiang ZOU ; Qi SHU ; Shuang WU ; Jiahui YU ; Xuerui ZHANG ; Yuheng SUN ; Zhongyuan QU
China Pharmacy 2023;34(8):935-940
OBJECTIVE To analyze the main components of Chelidonii Herba-Corydalis Rhizoma (CHCR), and to predict pharmacodynamic substances against estrogen receptor (ER) -positive breast cancer and their potential targets and signaling pathways, followed by verifying experiments. METHODS The ethanol extract of CHCR was analyzed by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS/MS). The network pharmacology analysis was performed for the screened components. The network diagram of CHCR “active components-target-pathway” was constructed, and the enrichment pathway in vitro was validated. RESULTS A total of 58 chemical components were identified, including 57 alkaloids and 1 organic acid. A total of 38 active ingredients were screened from the network pharmacology, and 38 core targets were found in the protein-protein interaction network of “component-disease” intersection targets; 258 gene ontology entries and 137 Kyoto encyclopedia of genes and genomics pathways were obtained, mainly including estrogen signal pathway, phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt) signal pathway, etc. The results of validation test showed that the median inhibitory concentration of CHCR to MCF-7 cells was 693 μg/mL; 150, 300, 600 μg/mL CHCR could significantly reduce the expressions of phosphorylated PI3K, phosphorylated Akt, ERα protein and ESR1 mRNA (P<0.01). CONCLUSIONS The anti-ER-positive breast cancer effect of CHCR may be related to the regulation of ER and PI3K/Akt pathways, which has the characteristics of multi-component and multi-target effects.
7.Visual analysis of research hotspots of diabetic sarcopenia in the past decade based on CiteSpace
Jiahui LI ; Shengqiang ZOU ; Qi XUE ; Xuefei WU
Chinese Journal of Modern Nursing 2023;29(6):804-810
Objective:To analyze the research hotspots and evolution trends of diabetes patients with sarcopenia in the past decade, and to provide ideas for domestic research on diabetics patients with sarcopenia.Methods:Relevant literature on diabetics patients with sarcopenia included in the Web of Science from 2011 to 2021 was retrieved. CiteSpace software was used to analyze country, cited journals, cited literature and high-frequency keywords.Results:A total of 606 papers were included, and the number of papers published increased in the past decade. The country with the most publications was Japan. Research hotspots included the use of diabetic sarcopenia assessment tools, pathogenesis, and the prediction of other disease-related factors. However the number of intervention research was small.Conclusions:In clinical work, health care professionals and related workers should pay attention to the importance of disease care and self-management of diabetic patients, provide personalized care and treatment to reduce or prevent the occurrence of sarcopenia, so as to promote the research of diabetic sarcopenia in China.
8.Current research trends of nanomedicines.
Qiuyue LIU ; Jiahui ZOU ; Zhongjian CHEN ; Wei HE ; Wei WU
Acta Pharmaceutica Sinica B 2023;13(11):4391-4416
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received widespread attention with significantly improved efficacy and reduced non-target side effects. Nanomedicines hold tremendous theranostic potential for treating, monitoring, diagnosing, and controlling various diseases and are attracting an unfathomable amount of input of research resources. Against the backdrop of an exponentially growing number of publications, it is imperative to help the audience get a panorama image of the research activities in the field of nanomedicines. Herein, this review elaborates on the development trends of nanomedicines, emerging nanocarriers, in vivo fate and safety of nanomedicines, and their extensive applications. Moreover, the potential challenges and the obstacles hindering the clinical translation of nanomedicines are also discussed. The elaboration on various aspects of the research trends of nanomedicines may help enlighten the readers and set the route for future endeavors.
9.Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma.
Wenqiang YAN ; Huishou FAN ; Jingyu XU ; Jiahui LIU ; Lingna LI ; Chenxing DU ; Shuhui DENG ; Weiwei SUI ; Yan XU ; Dehui ZOU ; Lugui QIU ; Gang AN
Chinese Medical Journal 2023;136(14):1744-1746
10.Relationship between pancreatic fibrotic markers and glycated hemoglobin levels in patients with type 3c diabetes mellitus secondary to chronic pancreatitis
Jun YE ; Yu CAO ; Jiahui ZHU ; Xiaotong MAO ; Yuanchen WANG ; Jinjin XIE ; Wenbin ZOU ; Yangyang QIAN ; Zhaoshen LI ; Zhuan LIAO
Chinese Journal of Pancreatology 2022;22(2):93-97
Objective:To investigate the relationship between pancreatic fibrotic marker transforming growth factor-β(TGF-β) and platelet derived growth factor-BB(PDGF-BB) and serum glycated hemoglobin (HbA1c) levels in patients with type 3c diabetes mellitus secondary to chronic pancreatitis(CP-T3cDM).Methods:The clinical data of 39 patients with CP-T3cDM admitted to the Department of Gastroenterology of the First Affiliated Hospital of Naval Medical University between February 2018 and August 2020 were collected, and the patients' age, gender, body mass index, duration of chronic pancreatitis and diabetes mellitus, smoking history, alcohol consumption history, serum HbA1c level at admission, degree of pancreatic atrophy, morphology of the main pancreatic duct, and treatment of diabetes mellitus were recorded. Serum TGF-β and PDGF-BB were detected by ELISA. Patients were divided into high and low level group according to the median TGF-β and PDGF-BB levels, respectively. Clinical characteristics of patients were compared between the TGF-β and PDGF-BB high and low level group. The correlation between TGF-β, PDGF-BB and HbA1c was analyzed by Spearman's correlation analysis.Results:A total of 39 CP-T3cDM patients were included; 35 were male and 4 were female. The age of first onset of chronic pancreatitis was (42±14) years old, and the duration of diabetes mellitus was 24(4, 36) months. The serum HbA1c level was (7.8±1.6)%, and the serum TGF-β and PDGF-BB levels were 20.5(10.5, 43.1) and 647.5(276.9, 1349.2)pg/ml, respectively. The serum HbA1c levels of patients in the high-level group of serum TGF-β and PDGF-BB were significantly higher than those in the corresponding low-level group [8.6%(7.4%, 9.9%) vs 6.7%(6.2%, 7.8%) and 8.6%(7.4%, 9.6%) vs 6.7%(6.1%, 7.8%), respectively] , and the difference was statistically different (both P value <0.01), while none of other indicators showed statistically significant differences between both groups. The correlation analysis showed that the levels of TGF-β and PDGF-BB were significantly positively correlated with HbA1c level ( r=0.45, 0.53, both P value <0.01). Conclusions:Increased pancreatic fibrosis in patients with CP-T3cDM was an important factor contributing to elevated blood glucose level. Patients with higher serum pancreatic fibrotic factors exhibited a significant increase in HbA1c level.


Result Analysis
Print
Save
E-mail